News
CHJTF
1.390
NaN%
--
CSPC Wins U.S. FDA Nod for Trials of Long-Acting Octreotide Injection
TipRanks · 22h ago
CSPC’s Secukinumab Biosimilar Application Accepted by China’s NMPA
TipRanks · 22h ago
CSPC’s Efmedaglutide Alfa Wins Second NMPA Review for Type 2 Diabetes
TipRanks · 22h ago
CSPC Pharmaceutical Trustee Buys Shares for 2026 Award Scheme
TipRanks · 1d ago
CSPC Pharmaceutical Expands On-Market Buybacks for 2026 Share Award Scheme
TipRanks · 2d ago
CSPC Wins NMPA Review Nod for Novel Hypertension Combo Pill
TipRanks · 2d ago
CSPC Wins China Approval for First Quick-Dissolving Albumin-Bound Paclitaxel
TipRanks · 3d ago
CSPC’s Anbenitamab Combo Hits Phase III Goal in HER2-Positive Breast Cancer
TipRanks · 06/10 11:14
CSPC Pharma Trustee Buys HK$15 Million in Shares for 2026 Award Scheme
TipRanks · 06/09 11:08
CSPC Pharmaceutical Expands 2026 Share Award Pool with On-Market Buy
TipRanks · 06/08 12:44
CSPC Grants 1.35 Million Restricted Shares Under 2018 Incentive Scheme
TipRanks · 06/08 12:10
CSPC Wins U.S. FDA Nod for Once-Monthly Semaglutide Trial
TipRanks · 06/08 12:10
CSPC Pharmaceutical Announces Retirement of Executive Director Wang Huaiyu
TipRanks · 06/05 10:13
CSPC Pharmaceutical Group Updates Board and Committee Structure
TipRanks · 06/05 10:13
Citic Securities Sticks to Their Buy Rating for CSPC Pharmaceutical Group (CHJTF)
TipRanks · 06/05 01:55
CSPC Pharmaceutical Group (CHJTF) Receives a Hold from BOCOM International Holdings Company
TipRanks · 06/05 00:26
CSPC Pharmaceutical Buys 13.8 Million Shares for 2026 Award Scheme
TipRanks · 06/03 11:42
Madrigal Pharmaceuticals Could Become The Next Vertex
Seeking Alpha · 06/03 01:40
UBS Sticks to Its Buy Rating for CSPC Pharmaceutical Group (CHJTF)
TipRanks · 06/03 00:32
CSPC Reports Promising Early ASCO Data for Novel B7-H3 Antibody-Drug Conjugate SYS6043
TipRanks · 06/02 11:03
More
Webull provides a variety of real-time CHJTF stock news. You can receive the latest news about Cspc Pharmaceut through multiple platforms. This information may help you make smarter investment decisions.
About CHJTF
CSPC Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company sells its products under the brand of CSPS. The Company has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs), Vitamin C (bulk drugs) and Caffeine and Others (bulk drugs). All these segments are engaged in the manufacture and sales of related pharmaceutical products. The finished drugs include the antibiotics, cardio-cerebrovascular drugs, diabetes drugs, neurology drugs, oncology drugs and traditional Chinese medicines. The Company is also engaged in the provision of pharmaceutical research and development services, as well as the processing of sewage and pharmaceutical by-products through its subsidiaries.